Skip Navigation

Corrigendum for Aapro et al., Ann Oncol 14 (3) 441-448.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aapro, M. S.
Right arrow Articles by Vermorken, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aapro, M. S.
Right arrow Articles by Vermorken, J. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:811, 2003
© 2003 European Society for Medical Oncology

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupAnn Oncol 2003; 14: 441–448

M. S. Aapro, F. H. van Wijk, G. Bolis, B. Chevallier, M. E. L. van der Burg, A. Poveda, C. F. de Oliveira, S. Tumolo, V. Scotto di Palumbo, M. Piccart, M. Franchi, F. Zanaboni, A. J. Lacave, R. Fontanelli, G. Favalli, P. Zola, J. P. Guastalla, R. Rosso, C. Marth, M. Nooij, M. Presti, C. Scarabelli, T. A. W. Splinter, E. Ploch, L. V. A. Beex, W. ten Bokkel Huinink, M. Forni, M. Melpignano, P. Blake, P. Kerbrat, C. Mendiola, A. Cervantes, A. Goupil, P. G. Harper, C. Madronal, M. Namer, G. Scarfone, J. E. G. M. Stoot, I. Teodorovic, C. Coens, I. Vergote and J. B. Vermorken

The authors wish to correct the authorship of the above paper. The first and second authors should be transposed so that the correct order is as follows:

F. H. van Wijk, M. S. Aapro, G. Bolis, B. Chevallier, M. E. L. van der Burg, A. Poveda, C. F. de Oliveira, S. Tumolo, V. Scotto di Palumbo, M. Piccart, M. Franchi, F. Zanaboni, A. J. Lacave, R. Fontanelli, G. Favalli, P. Zola, J. P. Guastalla, R. Rosso, C. Marth, M. Nooij, M. Presti, C. Scarabelli, T. A. W. Splinter, E. Ploch, L. V. A. Beex, W. ten Bokkel Huinink, M. Forni, M. Melpignano, P. Blake, P. Kerbrat, C. Mendiola, A. Cervantes, A. Goupil, P. G. Harper, C. Madronal, M. Namer, G. Scarfone, J. E. G. M. Stoot, I. Teodorovic, C. Coens, I. Vergote & J. B. Vermorken

On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Gynaecological Cancer Group


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aapro, M. S.
Right arrow Articles by Vermorken, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aapro, M. S.
Right arrow Articles by Vermorken, J. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?